Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
'I just thought that was the best thing for me to do at this point': Exploring patient experiences with depot buprenorphine and their motivations to discontinue.
Clay S, Treloar C, Degenhardt L, Grebely J, Christmass M, Gough C, Hayllar J, McDonough M, Henderson C, Crawford S, Farrell M, Marshall A. Clay S, et al. Among authors: christmass m. Int J Drug Policy. 2023 May;115:104002. doi: 10.1016/j.drugpo.2023.104002. Epub 2023 Mar 30. Int J Drug Policy. 2023. PMID: 37003194 Free article.
Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial.
Acheson LS, Ezard N, Lintzeris N, Dunlop A, Brett J, Rodgers C, Gill A, Christmass M, McKetin R, Farrell M, Shoptaw S, Siefried KJ. Acheson LS, et al. Among authors: christmass m. Drug Alcohol Depend. 2022 Dec 1;241:109692. doi: 10.1016/j.drugalcdep.2022.109692. Epub 2022 Nov 7. Drug Alcohol Depend. 2022. PMID: 36399936 Free article. Clinical Trial.
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial.
McKetin R, Degan TJ, Saunders L, Nguyen L, Dore G, Shoptaw S, Farrell M, Degenhardt L, Kelly PJ, Turner A, Clare PJ, Dean OM, Arunogiri S, Colledge-Frisby S, Koeijers J, Goodman-Meza D, Sinclair B, Reid D, Hill H, Hayllar J, Christmass M, Cordaro F, Lundin R, Liaw W, Liu D, Holyoak E, Wu BT, Keygan J, Kontogiannis A, Palmer L, Morrison C, Wrobel A, Hyland B, Byrne M, Russell S, Zahra E, Berk M. McKetin R, et al. Among authors: christmass m. Trials. 2024 Jun 22;25(1):408. doi: 10.1186/s13063-024-08238-y. Trials. 2024. PMID: 38907288 Free PMC article.
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs.
Broady TR, Valerio H, Alavi M, Wheeler A, Silk D, Martinello M, Conway A, Milat A, Dunlop A, Murray C, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Stevens A, Prain B, Hayllar J, Reid D, Montebello M, Wade A, Christmass M, Cock V, Dore GJ, Treloar C, Grebely J; ETHOS Engage Study Group. Broady TR, et al. Among authors: christmass m. Int J Drug Policy. 2024 Jun;128:104468. doi: 10.1016/j.drugpo.2024.104468. Epub 2024 May 24. Int J Drug Policy. 2024. PMID: 38795465 Free article.
The reflections of health service providers on implementing contingency management for methamphetamine use disorder in Australia.
Clay S, Wilkinson Z, Ginley M, Arunogiri S, Christmass M, Membrey D, MacCartney P, Sutherland R, Colledge-Frisby S, Marshall AD, Nagle J, Degenhardt L, Farrell M, McKetin R. Clay S, et al. Among authors: christmass m. Drug Alcohol Rev. 2024 Jul;43(5):1313-1322. doi: 10.1111/dar.13853. Epub 2024 May 5. Drug Alcohol Rev. 2024. PMID: 38704742
25 results